VRTX

NASD Vertex Pharmaceuticals Incorporated

Nov 7, 2026 · 3:27 AM ET EOD Market Closed

$547.09 ↑ +0.00 (+0.00%) Trading Up from the previous close of $547.09, $1.67 below the day’s high of $548.76

YTD change: +20.67%
vs 20-day SMA: +4.69%
vs 200-day SMA: +13.70%

Price ranges

Previous day

$531.53 $548.76

open $531.53 close $547.09

+$15.56 (+2.93%)

Today

$531.53 $548.76

$547.09

Past week

$527.38 $568.67

from $540.00 now $547.09

+$7.09 (+1.31%)

Past month

$484.08 $568.67

from $503.25 now $547.09

+$43.84 (+8.71%)

This year

$412.27 $568.67

from $453.36 now $547.09

+$93.73 (+20.67%)

Price & Performance

+122.09 (+28.73%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good

The stock is 3.8% away from all-time highs of $568.67
VRTX is up 21% since the beginning of the year
VRTX is up 31% over the past 12 months
VRTX is up 9% over the past 1 month
2% of all VRTX investors are betting against VRTX

VRTX reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +33.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes

EPS $4.76

Earnings momentum -12.6% Quarterly EPS growth

Quarterly change -12.6%

Valuation

P/E ratio 35.35

Enterprise value $138.6B

Beta 0.17

Balance sheet & scale

Income$4.0M

Revenue$13.0B

Cash$6.3B

Debt$6.5M

Income / Debt 0.61×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Manufacturing

Sub Sector Chemical Manufacturing

Market cap $138.7B

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Competitor comparison

Ticker	Company	Price	Change
LLY	Eli Lilly and Company	$1,354.00	-0.79%
JNJ	Johnson & Johnson	$276.22	+1.43%
ABBV	AbbVie, Inc.	$291.31	+1.07%
MRK	Merck & Co., Inc.	$146.73	-0.14%
RHHBY	Roche Holding Ltd Sponsored ADR	$59.37	-0.13%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.